{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:59:18Z","timestamp":1792508358583,"version":"4.5.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2021,7,1]]},"DOI":"10.1001\/jamaoncol.2021.1074","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T20:26:28Z","timestamp":1620419188000},"page":"993","source":"Crossref","is-referenced-by-count":78,"title":["Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant"],"prefix":"10.1001","volume":"7","author":[{"given":"Michael","family":"Scordo","sequence":"first","affiliation":[{"name":"Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Medicine, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trent P.","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang W.","family":"Ahn","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee"},{"name":"Institute for Health and Equity, Division of Biostatistics, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sairah","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrukh T.","family":"Awan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Beitinjaneh","sequence":"additional","affiliation":[{"name":"Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Oregon Health and Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor A.","family":"Chow","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagirathbhai","family":"Dholaria","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendranath","family":"Epperla","sequence":"additional","affiliation":[{"name":"The James Cancer Hospital and Solove Research Institute, Division of Hematology, Department of Medicine, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Farooq","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilanjan","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Levine Cancer Institute, Department of Hematologic Oncology and Blood Disorders, Atrium Health, Charlotte, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Grover","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of North Carolina Hospitals, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Hamad","sequence":"additional","affiliation":[{"name":"St Vincent\u2019s Hospital, Darlinghurst, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard C.","family":"Hildebrandt","sequence":"additional","affiliation":[{"name":"Markey Cancer Center, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"Holmberg","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghee","family":"Hong","sequence":"additional","affiliation":[{"name":"Blood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Inwards","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Jimenez-Jimenez","sequence":"additional","affiliation":[{"name":"Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Karmali","sequence":"additional","affiliation":[{"name":"Department of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishalee P.","family":"Kenkre","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Wisconsin\u2013Madison, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Khimani","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Klyuchnikov","sequence":"additional","affiliation":[{"name":"Department for Stem Cell Transplantation, University Cancer Center, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell M.","family":"Krem","sequence":"additional","affiliation":[{"name":"Markey Cancer Center, University of Kentucky, Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pashna N.","family":"Munshi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Georgetown University Hospital, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yago","family":"Nieto","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Prestidge","sequence":"additional","affiliation":[{"name":"Blood and Cancer Centre, Starship Children\u2019s Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Ramakrishnan Geethakumari","sequence":"additional","affiliation":[{"name":"Lymphoma, BMT and Cellular Therapy Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Rezvani","sequence":"additional","affiliation":[{"name":"Division of Blood & Marrow Transplantation, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Riedell","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Chicago Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav N.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melhem","family":"Solh","sequence":"additional","affiliation":[{"name":"The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean A.","family":"Yared","sequence":"additional","affiliation":[{"name":"Blood & Marrow Transplantation Program, Greenebaum Comprehensive Cancer Center, Division of Hematology\/Oncology, Department of Medicine, University of Maryland, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Kharfan-Dabaja","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Herrera","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hamadani","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S.","family":"Sauter","sequence":"additional","affiliation":[{"name":"Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Department of Medicine, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"21","key":"coi210012r1","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1200\/JCO.2017.72.7602","article-title":"Primary CNS Lymphoma.","volume":"35","author":"Grommes","year":"2017","journal-title":"J Clin Oncol"},{"issue":"25","key":"coi210012r2","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1200\/JCO.2012.46.9957","article-title":"Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).","volume":"31","author":"Rubenstein","year":"2013","journal-title":"J Clin Oncol"},{"issue":"13","key":"coi210012r3","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1182\/blood-2015-10-636340","article-title":"The role of autologous stem cell transplantation in primary central nervous system lymphoma.","volume":"127","author":"Ferreri","year":"2016","journal-title":"Blood"},{"issue":"9","key":"coi210012r4","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1182\/blood-2014-10-604561","article-title":"R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.","volume":"125","author":"Omuro","year":"2015","journal-title":"Blood"},{"issue":"11","key":"coi210012r5","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1016\/S2352-3026(17)30174-6","article-title":"Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.","volume":"4","author":"Ferreri","year":"2017","journal-title":"Lancet Haematol"},{"issue":"7","key":"coi210012r6","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.3324\/haematol.2017.185843","article-title":"Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients.","volume":"103","author":"Birsen","year":"2018","journal-title":"Haematologica"},{"issue":"10","key":"coi210012r7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1200\/JCO.18.00306","article-title":"Radiotherapy or autologous stem-cell transplantation for primary CNS lymphoma in patients 60 years of age and younger: results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study.","volume":"37","author":"Houillier","year":"2019","journal-title":"J Clin Oncol"},{"issue":"22","key":"coi210012r8","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1200\/JCO.2003.05.024","article-title":"Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.","volume":"21","author":"Abrey","year":"2003","journal-title":"J Clin Oncol"},{"issue":"6","key":"coi210012r9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.bmt.1705452","article-title":"High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.","volume":"38","author":"Colombat","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"coi210012r10","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.bbmt.2015.02.005","article-title":"Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.","volume":"21","author":"Chen","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"24","key":"coi210012r11","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1200\/JCO.2006.06.2117","article-title":"High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.","volume":"24","author":"Illerhaus","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi210012r12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3324\/haematol.11771","article-title":"High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.","volume":"93","author":"Illerhaus","year":"2008","journal-title":"Haematologica"},{"issue":"8","key":"coi210012r13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/sj.bmt.1703917","article-title":"High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.","volume":"31","author":"Cheng","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"15","key":"coi210012r14","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1200\/JCO.2007.13.5533","article-title":"Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Mo\u00eblle Osseuse-Th\u00e9rapie Cellulaire.","volume":"26","author":"Soussain","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi210012r15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbmt.2011.07.006","article-title":"Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma.","volume":"18","author":"Cote","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"coi210012r16","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1016\/S2352-3026(16)30050-3","article-title":"High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.","volume":"3","author":"Illerhaus","year":"2016","journal-title":"Lancet Haematol"},{"issue":"5","key":"coi210012r17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.bbmt.2019.01.020","article-title":"High-dose chemotherapy with autologous stem cell transplantation in primary central nervous system lymphoma: data from the Japan Society for Hematopoietic Cell Transplantation Registry.","volume":"25","author":"Kondo","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"coi210012r18","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/j.clml.2018.11.018","article-title":"Autologous stem-cell transplantation for primary central nervous system lymphoma: systematic review and meta-analysis.","volume":"19","author":"Alnahhas","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"coi210012r19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbmt.2016.09.024","article-title":"A comprehensive assessment of toxicities in patients with central nervous system lymphoma undergoing autologous stem cell transplantation using thiotepa, busulfan, and cyclophosphamide conditioning.","volume":"23","author":"Scordo","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"27","key":"coi210012r20","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"coi210012r22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF00985764","article-title":"Score test of homogeneity for survival data.","volume":"1","author":"Commenges","year":"1995","journal-title":"Lifetime Data Anal"},{"issue":"2","key":"coi210012r23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cmpb.2007.07.010","article-title":"A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model.","volume":"88","author":"Zhang","year":"2007","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"coi210012r24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmpb.2010.07.005","article-title":"SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models.","volume":"101","author":"Zhang","year":"2011","journal-title":"Comput Methods Programs Biomed"},{"issue":"3","key":"coi210012r25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/1040-8428(92)90092-5","article-title":"Pharmacology of agents used in bone marrow transplant conditioning regimens.","volume":"13","author":"Wiebe","year":"1992","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"coi210012r26","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.bbmt.2018.04.013","article-title":"Distinctive infectious complications in patients with central nervous system lymphoma undergoing thiotepa, busulfan, and cyclophosphamide-conditioned autologous stem cell transplantation.","volume":"24","author":"Scordo","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"coi210012r27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1182\/blood-2016-01-650101","article-title":"The role of whole brain radiation in primary CNS lymphoma.","volume":"128","author":"Kasenda","year":"2016","journal-title":"Blood"},{"key":"coi210012r28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/EDBK_242547","article-title":"Evolving treatments for primary central nervous system lymphoma.","volume":"39","author":"Ferreri","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"2","key":"coi210012r29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1200\/JCO.2003.09.139","article-title":"Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience.","volume":"21","author":"Ferreri","year":"2003","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi210012r30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/bmt.2010.71","article-title":"Feasibility of BU, CY and etoposide (BUCYE), and auto-SCT in patients with newly diagnosed primary CNS lymphoma: a single-center experience.","volume":"46","author":"Yoon","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"coi210012r31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12185-014-1608-9","article-title":"Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma.","volume":"100","author":"Miyao","year":"2014","journal-title":"Int J Hematol"},{"issue":"8","key":"coi210012r32","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.bbmt.2019.04.004","article-title":"Outcomes of consecutively diagnosed primary central nervous system lymphoma patients using the Alberta Lymphoma Clinical Practice Guideline incorporating thiotepa-busulfan conditioning for transplantation-eligible patients.","volume":"25","author":"Sanders","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"coi210012r33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3109\/10428194.2014.916800","article-title":"Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide.","volume":"56","author":"Welch","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"16","key":"coi210012r34","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1002\/cncr.v123.16","article-title":"High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.","volume":"123","author":"DeFilipp","year":"2017","journal-title":"Cancer"},{"issue":"12","key":"coi210012r35","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.clml.2017.08.100","article-title":"High-dose thiotepa, busulfan, cyclophosphamide, and autologous stem cell transplantation as upfront consolidation for systemic non-Hodgkin lymphoma with synchronous central nervous system involvement.","volume":"17","author":"Qualls","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"coi210012r36","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3324\/haematol.2012.077917","article-title":"Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas.","volume":"98","author":"Korfel","year":"2013","journal-title":"Haematologica"},{"issue":"14","key":"coi210012r37","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1182\/bloodadvances.2020002064","article-title":"High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study.","volume":"4","author":"Schorb","year":"2020","journal-title":"Blood Adv"},{"key":"coi210012r21","doi-asserted-by":"crossref","DOI":"10.1007\/b97377","volume-title":"Survival Analysis: Techniques for Censored and Truncated Data","author":"Klein","year":"2003"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2779525\/jamaoncology_scordo_2021_oi_210012_1626360284.75352.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T15:02:58Z","timestamp":1626361378000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2779525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2021.1074","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,1]]}}}